Résumé
La généralisation du Dépistage Organisé du Cancer du Sein (DOCS) engendre la découverte de nombreuses images infracliniques, la majorité d’entre elles étant bénignes. Pour améliorer la standardisation de la description des images et plus encore de la conduite à tenir, l’American College of Radiology (ACR) a défini un système de cotation des images mammaires en fonction de leur valeur prédictive positive (VPP) de cancer dénommé Breast Imaging Reporting and Data System (Bi-Rads). Six catégories (de 1 à 6) ont été définies, initialement pour la mammographie mais aujourd’hui étendues à l’échographie et l’IRM [1].
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Références
American College of Radiology (ACR) ACR BI RADS (2003) Breast imaging and Data System. Breast imaging atlas. 4th ed. Reston, VA: American College of Radiology
Jørgensen KJ, Keen JD, Gøtzsche PC (2011) Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology 260: 621–627
Colin C, Forray N (2012) DNA damage induced by mammography in high family risk patient: one sigle view in screening. Breast 21: 409–410
Varas X, Leborgne J, Leborgne F et al. (2002) Revisiting the mammographic follow up of Bi-Rads catégory 3 lesions AJR 179: 691–695
Bowles E, Sickles E, Miglioretti D, Carney PA, Elmore JG (2010) Recommendation for shortinterval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance? AJR Am J Roentgenol 194: 1152–1159
Kim SJ, Chang JM, Chung SY, Chung SY, Han W, Moon WK (2012) Outcome of breast lesion detected at screening US. Eur J Radiol [Epub ahead of print]
Eby PR, DeMartini WB, Gutierrez RL et al. (2009) Characteristics of probably benign breast MRI lesions. AJR Am J Roentgenol 193: 861–867
Hauth E, Umutlu L, Kümmel S et al. (2010) Follow-up of probably benign lesions (BI-RADS 3 category) in breast MR imaging. Breast J 16: 297–304
Kim EK, Ko KH, Oh KK, Kwak JY et al. (2008) Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography. AJR Am J Roentgenol 190: 1209–1215
Baum JK, Hanna LG, Acharyya S et al. (2011) Use of Bi-Rads 3 category in the American college of radiology imaging Network digital mammographic imaging screening trial. Radiology 260: 61–69
Lehman CD, Rutter CM, Eby PR et al. (2008) Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography. AJR 190: 511–515
Harvey JA, Nicholson BT, Lorusso AP et al. (2009) Short term follow up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women. AJR 193: 1723–1730
Razza S, Chikarmane S, Neilsen S et al. (2008) Bi-Rads 3, 4, 5 lesions: value of US in management-follow up and outcome. Radiology 248: 773–781
Kim SJ, Ko EY, Shin JH et al. (2008) Application of sonographic BI-RADS to synchronous breast nodules detected in patients with breast cancer. AJR Am J Roentgenol 191: 653–658
Pijnappel R, Peeters P, Hendricks H et al. (2004) Reproducibility of mammographic classifisifications for non palpable suspect lesion with microcalcifications. BJR 77: 312–314
Obenauer S, Hermann KP, Grabbe E (2005) Applications and literature review of the BI-RADS classification. Eur Radiol 15: 1027–1036
Lai XJ, Zhu QL, Jiang YX (2011) WITHDRAWN: Inter-observer variability in Breast Imaging Reporting and Data System (BI-RADS) ultrasound final assessments. Eur J Radiol [Epub ahead of print]
Abdullah N, Mesurolle B, El Khoury M et al. (2009) Breast imaging reporting and data system for US: Interobserver for assessment of breast masses Radiology 252: 665–672
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France, Paris
About this paper
Cite this paper
Ceugnart, L. et al. (2013). Prélever ou surveiller : acquis et limites de la classification Bi-Rads. In: Acquis et limites en sénologie / Assets and limits in breast diseases. Springer, Paris. https://doi.org/10.1007/978-2-8178-0396-8_3
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0396-8_3
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0395-1
Online ISBN: 978-2-8178-0396-8